Ovarian cancer differential diagnosis: Difference between revisions

Jump to navigation Jump to search
VisualWikitext
No edit summary
No edit summary
Line 10: Line 10:
|- style="background: #4479BA; color: #FFFFFF; text-align: center;"
|- style="background: #4479BA; color: #FFFFFF; text-align: center;"
! colspan="2" rowspan="4" |Diseases
! colspan="2" rowspan="4" |Diseases
| colspan="7" |'''Clinical manifestations'''
| colspan="9" |'''Clinical manifestations'''
! colspan="4" rowspan="2" |Para-clinical findings
! colspan="4" rowspan="2" |Para-clinical findings
| colspan="1" rowspan="4" style="background: #4479BA; color: #FFFFFF; text-align: center;" |'''Gold standard'''
| colspan="1" rowspan="4" style="background: #4479BA; color: #FFFFFF; text-align: center;" |'''Gold standard'''
! rowspan="4" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Additional findings
! rowspan="4" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Additional findings
|-
|-
| rowspan="3" |Specific risk factors
| rowspan="3" |Age of onset
| rowspan="3" |Age of onset
| colspan="3" rowspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |'''Symptoms'''
| colspan="4" rowspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |'''Symptoms'''
! colspan="3" rowspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Physical examination
! colspan="3" rowspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Physical examination
|-
|-
Line 25: Line 26:
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |pelvic pain or pressure
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |pelvic pain or pressure
! colspan="1" rowspan="1" style="background: #4479BA; color: #FFFFFF; text-align: center;" |vaginal discharge
! colspan="1" rowspan="1" style="background: #4479BA; color: #FFFFFF; text-align: center;" |vaginal discharge
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Symptom 3
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |GI dysturbance
!'''Constitutional'''
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |'''Pleural effusion'''  
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |'''Pleural effusion'''  
! colspan="1" rowspan="1" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Physical exam 2
! colspan="1" rowspan="1" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Physical exam 2
Line 32: Line 34:
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |MRI
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |MRI
|-
|-
! colspan="15" style="background: #7d7d7d; color: #FFFFFF; text-align: center;" |Gynecologic
! colspan="17" style="background: #7d7d7d; color: #FFFFFF; text-align: center;" |Gynecologic
|-
| rowspan="14" |Ovarian
|Follicular or corpus luteum cysts
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|-
|-
| rowspan="13" style="background: #DCDCDC; padding: 5px; text-align: center;" |Ovarian
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Serous cystadenoma/carcinoma
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Serous cystadenoma/carcinoma
|
|
|
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
|
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
Line 51: Line 72:
|-
|-
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Mucinous cystadenoma/carcinoma
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Mucinous cystadenoma/carcinoma
|
|
|
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
|
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
Line 66: Line 89:
|-
|-
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Endometrioma
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Endometrioma
|
|
|
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
|
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
Line 78: Line 103:
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |infertility
|-
|-
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Teratoma
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Teratoma
|
|
|
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
|
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
Line 96: Line 123:
|-
|-
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Dysgerminoma
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Dysgerminoma
|
|
|
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
|
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
Line 111: Line 140:
|-
|-
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Choriocarcinoma
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Choriocarcinoma
|
|
|
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
|
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
Line 126: Line 157:
|-
|-
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Yolk sac tumor
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Yolk sac tumor
|
|
|
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
|
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
Line 141: Line 174:
|-
|-
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Fibroma
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Fibroma
|
|
|
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
|
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
Line 156: Line 191:
|-
|-
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Thecoma
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Thecoma
|
|
|
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
|
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
Line 171: Line 208:
|-
|-
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Granulosa cell tumor
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Granulosa cell tumor
|
|
|
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
|
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
Line 186: Line 225:
|-
|-
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Sertoli-lydig cell tumor
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Sertoli-lydig cell tumor
|
|
|
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
|
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
Line 201: Line 242:
|-
|-
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Brenner tumor
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Brenner tumor
|
|
|
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
|
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
Line 216: Line 259:
|-
|-
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Metastasis (krukenberg)
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Metastasis (krukenberg)
|
|
|
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
|
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
Line 230: Line 275:
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
|-
|-
| rowspan="5" style="background: #DCDCDC; padding: 5px; text-align: center;" |Tubal
| rowspan="6" |Tubal
|tubo-ovarian abscess
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|fever and vaginal discharge
|-
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Ectopic pregnancy
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Ectopic pregnancy
|
|
|
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
|
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
Line 247: Line 311:
|-
|-
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Hydrosalpinx
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Hydrosalpinx
|
|
|
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
|
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
Line 259: Line 325:
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |infertility
|-
|-
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Tuberculosis salpingitis
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Tuberculosis salpingitis
|
|
|
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
|
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
Line 277: Line 345:
|-
|-
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Epithelial carcinoma
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Epithelial carcinoma
|
|
|
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
|
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
Line 292: Line 362:
|-
|-
| style="background: #DCDCDC; padding: 5px; text-align: center;" |serous tubal intraepithelial neoplasm
| style="background: #DCDCDC; padding: 5px; text-align: center;" |serous tubal intraepithelial neoplasm
|
|
|
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
|
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
Line 308: Line 380:
| rowspan="3" style="background: #DCDCDC; padding: 5px; text-align: center;" |Uterine
| rowspan="3" style="background: #DCDCDC; padding: 5px; text-align: center;" |Uterine
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Myoma
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Myoma
|
|
|
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
|
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
Line 323: Line 397:
|-
|-
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Sarcoma
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Sarcoma
|
|
|
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
|
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
Line 338: Line 414:
|-
|-
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Pregnancy
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Pregnancy
|
|
|
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
|
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
Line 352: Line 430:
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
|-
|-
! colspan="15" style="background: #7d7d7d; color: #FFFFFF; text-align: center;" |Non-gynecologic
! colspan="17" style="background: #7d7d7d; color: #FFFFFF; text-align: center;" |Non-gynecologic
|-
|-
| rowspan="4" style="background: #DCDCDC; padding: 5px; text-align: center;" |GIT
| rowspan="4" style="background: #DCDCDC; padding: 5px; text-align: center;" |GIT
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Apppendiceal abscess
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Apppendiceal abscess
|
|
|
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
|
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
Line 371: Line 451:
|-
|-
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Appendiceal  neoplasm
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Appendiceal  neoplasm
|
|
|
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
|
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
Line 386: Line 468:
|-
|-
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Diverticular abscess
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Diverticular abscess
|
|
|
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
|
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
Line 401: Line 485:
|-
|-
| style="background: #DCDCDC; padding: 5px; text-align: center;" |GI neoplasm
| style="background: #DCDCDC; padding: 5px; text-align: center;" |GI neoplasm
|
|
|
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
|
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
Line 413: Line 499:
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |abdominal pain Intestinal obstruction and bleeding in small bowel,
|-
|-
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Renal
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Renal
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Pelvic kidney
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Pelvic kidney
|
|
|
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
|
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
Line 433: Line 521:
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Others
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Others
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Retroperitoneal sarcoma
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Retroperitoneal sarcoma
|
|
|
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
|
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
Line 447: Line 537:
| style="background: #F5F5F5; padding: 5px;" |Gastrointestinal symptoms, such as early satiety, obstruction,lower extremity edema, Serous ascites
| style="background: #F5F5F5; padding: 5px;" |Gastrointestinal symptoms, such as early satiety, obstruction,lower extremity edema, Serous ascites
|}
|}
check sites of cancer that may metastasize to the ovaries (eg, stomach, colorectal, breast)
check rectum, liver, spleen, lungs, inguinal or supraclavicular lymph nodes for ovary metastase


==References==
==References==

Revision as of 17:27, 24 January 2019

Ovarian cancer Microchapters

Home

Patient Information

Overview

Historical Perspective

Classifications

Pathophysiology

Causes of Ovarian cancer

Differentiating Ovarian cancer from other Diseases

Epidemiology & Demographics

Risk Factors

Screening

Natural History, Complications & Prognosis

Diagnosis

History & Symptoms

Physical Examination

Staging

Laboratory Findings

Chest X Ray

CT

MRI

Echocardiography or Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Ovarian cancer differential diagnosis On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Ovarian cancer differential diagnosis

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Ovarian cancer differential diagnosis

CDC on Ovarian cancer differential diagnosis

Ovarian cancer differential diagnosis in the news

Blogs on Ovarian cancer differential diagnosis

Directions to Hospitals Treating Ovarian cancer

Risk calculators and risk factors for Ovarian cancer differential diagnosis

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Fahimeh Shojaei, M.D.

Overview

Differentiating [Disease name] from other Diseases

Diseases Clinical manifestations Para-clinical findings Gold standard Additional findings
Specific risk factors Age of onset Symptoms Physical examination
Lab Findings Imaging Immunohistopathology
pelvic pain or pressure vaginal discharge GI dysturbance Constitutional Pleural effusion Physical exam 2 Physical exam 3 CT scan MRI
Gynecologic
Ovarian Follicular or corpus luteum cysts
Serous cystadenoma/carcinoma
Mucinous cystadenoma/carcinoma
Endometrioma infertility
Teratoma
Dysgerminoma
Choriocarcinoma
Yolk sac tumor
Fibroma
Thecoma
Granulosa cell tumor
Sertoli-lydig cell tumor
Brenner tumor
Metastasis (krukenberg)
Tubal tubo-ovarian abscess fever and vaginal discharge
Ectopic pregnancy
Hydrosalpinx infertility
Tuberculosis salpingitis
Epithelial carcinoma
serous tubal intraepithelial neoplasm
Uterine Myoma
Sarcoma
Pregnancy
Non-gynecologic
GIT Apppendiceal abscess
Appendiceal neoplasm
Diverticular abscess
GI neoplasm abdominal pain Intestinal obstruction and bleeding in small bowel,
Renal Pelvic kidney tract infection (UTI), obstruction, and renal calculi.
Others Retroperitoneal sarcoma Gastrointestinal symptoms, such as early satiety, obstruction,lower extremity edema, Serous ascites

check sites of cancer that may metastasize to the ovaries (eg, stomach, colorectal, breast)

check rectum, liver, spleen, lungs, inguinal or supraclavicular lymph nodes for ovary metastase

References

Template:WH Template:WS

Retrieved from "https://www.wikidoc.org/index.php?title=Ovarian_cancer_differential_diagnosis&oldid=1540601"